D. Southern

Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.

M. Blumenthal, C. Laforce, D. Pearlman, 1994, Annals of allergy.

Intranasal therapy with once-daily triamcinolone acetonide aerosol versus twice-daily beclomethasone dipropionate aqueous spray in patients with perennial allergic rhinitis

D. Webb, T. Casale, W. Pleskow, 1996 .

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.

R. Nathan, K. Nolop, R. Berkowitz, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

A study of antibody levels in alcoholic, depressive and schizophrenic patients.

A. Sugerman, J. Curran, D. Southern, 1982, Annals of allergy.

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.

J. Kemp, R. Dockhorn, A. van As, 1992, The New England journal of medicine.

Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis.

E. Bronsky, S. Findlay, M. Welch, 1994, Clinical therapeutics.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

S. Spector, J. Kemp, R. Nathan, 1998, The Journal of allergy and clinical immunology.

Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma.

J. Ramsdell, D. Aaronson, J. Grossman, 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.